$6.72
-0.77-10.28%
Last update: Nov 3, 4:26 AM
AgomAb Therapeutics NV
AGMBNASDAQ
Wall Street analyst price targets and consensus rating for AgomAb Therapeutics (AGMB).
Price Target Range — 3 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
